Search
Vaccines Treatment Options in Massachusetts
A collection of 146 research studies where Vaccines is the interventional treatment. These studies are located in the Massachusetts, United States. Vaccines is used for conditions such as Influenza, COVID-19 and Hepatitis B.
145 - 146 of 146
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
Unknown
This study will evaluate the safety of and immune response to a new HIV vaccine. The vaccine in this trial uses pieces of HIV DNA and HIV proteins. The vaccine itself cannot cause HIV infection or AIDS.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
09/25/2008
Locations: University of Massachusetts School of Medicine, Worcester, Massachusetts
Conditions: HIV Infections
Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia
Completed
The purpose of this study is to evaluate clinical and laboratory safety associated with the administration of GVAX leukemia vaccine and to determine the feasibility of generation of GVAX leukemia vaccine in subjects with acute myelogenous leukemia (AML).
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
12/18/2007
Locations: Dana Farber Cancer Institute, Boston, Massachusetts
Conditions: Acute Myelogenous Leukemia